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Purpose: Tyrosinase is the rate-limiting enzyme responsible for melanin biosynthesis in the retinal pigment epithelium
(RPE) of the eye. Melanin has an important role in retinal development, function, and protection against light-induced
oxidative stress, and melanin levels are associated with age-related macular degeneration (AMD). Because the levels of
and protection afforded by melanin seem to decline with increasing age, proper regulation of the human tyrosinase gene
(TYR) in the RPE is an important but insufficiently understood process. Our purpose was to obtain detailed information
on regulation of the TYR gene promoter in the human RPE and to specify the role of orthodenticle homeobox 2 (OTX2)
and microphthalmia-associated transcription factor (MITF).
Methods: We used luciferase reporter constructs to study regulation of the human TYR gene promoter in cultured human
RPE cells. We further studied the role of OTX2 and MITF, their binding sites, and endogenous expression by using
mutagenesis,  electrophoretic  mobility  shift  assay,  yeast  two-hybrid  assay,  RNA  interference,  and  gene  expression
analyses.
Results: In the RPE, OTX2 activated the human TYR gene promoter via direct trans-activation of novel OTX2 binding
elements. In addition, we found that indirect activation by OTX2 via more proximal MITF binding sites, even in the
absence of OTX2 sites, took place. These results are consistent with the physical interaction observed between OTX2 and
MITF. Overexpression or knockdown of OTX2 in RPE cells resulted in corresponding changes in tyrosinase mRNA
expression. Finally, we found that a single nucleotide polymorphism (SNP rs4547091) at the most proximal OTX2 binding
site is associated with altered nuclear protein binding and a remarkable decrease in TYR promoter activity in RPE cells.
This single nucleotide polymorphism (SNP) is more common in the European population in which AMD is also more
prevalent.
Conclusions: In the RPE, OTX2 activates the human TYR gene promoter by direct DNA binding and by interaction with
MITF. Such synergistic interaction highlights the role of OTX2 as a potential coregulator of numerous MITF target genes
in the eye. Genetic differences in OTX2 binding sites affect tyrosinase regulation. Collectively, these findings emphasize
the role of OTX2 in regulating the human TYR gene, with implications for inter-individual differences in melanin synthesis,
retinal development, and function as well as susceptibility to retinal degeneration associated with aging.
Tyrosinase (EC 1.14.18.1) is the rate-limiting enzyme
involved  in  melanin  biosynthesis,  catalyzing
dihydroxyphenylalanine  (L-DOPA)  formation  from  L-
tyrosine. Upon assistance by tyrosinase-related proteins 1 and
2 (TRP-1 and TRP-2), L-DOPA is converted into melanin
[1] in pigmented cells such as melanocytes in the skin and
retinal  pigment  epithelium  (RPE)  cells  of  the  eye  [2,3].
Melanin  can  exert  a  protective  function  in  tyrosinase-
expressing cells in several ways. First, melanin shields these
cells from the damage induced by sunlight and ultraviolet
radiation [4–6]. Second, melanin may counteract the oxidative
stress caused by free radicals derived from lipid peroxidation
products [7] and accumulated iron [8,9] in the RPE and in
substantia nigra. Such prooxidants may contribute to age-
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related degeneration of these tissues [10]. Third, the high
binding capacity of melanin for metal ions [11] and exogenous
chemicals [12–14] also lends support for a protective role of
melanin  in  the  eye.  In  concordance  with  these  findings,
melanin [15] and its precursors are essential for the proper
development of the retina in mammals [16,17]. Malfunctions
in  normal  expression  of  tyrosinase  [1,16],  its  post-
translational  modification  [18],  or  trafficking  into
melanosomes [19,20] can decrease pigmentation, the stability
of the melanosomes [21], and the normal functions of the RPE.
Researchers have shown that the content of the RPE cells
declines  with  age  [22],  perhaps  in  part  due  to  oxidative
degradation [5]. In addition, several age-related changes occur
in  melanin  [22,23],  contributing  to  its  functional  decline
[24].
Despite the importance of proper tyrosinase expression
for  the  RPE,  current  information  on  human  TYR  gene
regulation has mostly been gained in melanocytes of neural
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38crest origin [25]. Skin melanocytes continuously synthesize
and transport melanin into keratinocytes, while the majority
of  the  melanin  pigment  in  the  RPE  [21]  is  synthesized
prenatally during a few weeks of embryonic development and
stored in the melanosomes for the lifespan of the individual.
This suggests that any changes in TYR gene activity might
have profound and long-lasting effects on RPE physiology
and health. However, knowledge of tyrosinase expression in
the RPE, derived from the neuroectoderm, is scant and based
mainly on rodent data [26,27]. Unfortunately, no RPE cell
lines  display  tyrosinase  activity  and  active  melanogenesis
[28]. Primary RPE cells revert to the depigmented phenotype,
their melanosomes disappear, and the ability to form new
melanin is lost quickly after cell isolation [2,28,29]. Similar
dedifferentiation  to  the  amelanotic  phenotype  appears  in
melanoma cells where tyrosinase is not properly sorted into
melanosomes but is retained in the endoplasmic reticulum and
thereafter degraded [30,31].
The  current  evidence  indicates  that  two  transcription
factors,  the  microphthalmia-associated  transcription  factor
(MITF)  and  the  orthodenticle  homeobox  2  (OTX2),  are
responsible for the correct development of the retina as well
as for regulation of melanogenic genes. MITF’s importance
is highlighted by certain human MITF [32] and mouse Mitf
[33]gene mutations that result in abnormal melanogenesis,
compromised  RPE  function,  and  visual  problems.
Researchers  have  shown  that  binding  MITF  to  proximal
binding sites (termed M and E boxes) and to a more distal DNA
element (termed TDE) is important for the expression of the
TYR gene in melanocytes [25,34,35]. Isoforms of MITF that
differ in their N-terminal domains due to alternative promoter
usage [36,37] are expressed in a cell-specific manner: the
MITF-M isoform is present in the melanocytes while the
dominant isoforms in the mouse RPE are A, D, H, and J.
Isoforms A and J are also present in the neural retina [37,38].
However, very little is known about their roles with respect to
TYR gene regulation: the reporter gene activity is retained
even  with  N-terminally  truncated  MITF  variants  [37].
Therefore, we focused here on the best-characterized MITF-
A isoform.
The  homeodomain  protein  OTX2  is  involved  in  the
development of the retina [39,40] and brain [41–43], and
mutations in the human OTX2 and mouse Otx2 genes have
been associated with severe ocular malformations [44–46].
OTX2 appears to regulate enzymes necessary for the function
of  the  neural  retina  and  the  RPE  such  as  the  human
interphotoreceptor  retinoid  binding  protein  [47]  and  the
human  DOPAchrome  tautomerase  involved  in  melanin
synthesis  [48].  More  recently,  OTX2  has  been  found  to
activate  the  mouse  Tyr  [49]  and  human  bestrophin-1
(BEST1) gene promoters [50]. However, detailed studies on
regulation of the human TYR in the RPE are not clear, and the
role of the OTX2 factor has not been studied with this gene
promoter. This scant knowledge is associated with the scarcity
of good RPE cell models and lack of efficient gene delivery
methods [51]. Moreover, dissimilarities between the rodent
and human TYR promoter sequences near and at putative
OTX2 binding sites (ClustalW analysis of promoters up to
−462  bp)  may  compromise  the  use  of  mouse  models.
Therefore, our aim was to obtain more detailed information
on  regulation  of  the  human  TYR  promoter  and  mRNA
(mRNA) in human RPE cells by using the reverse transfection
technique [52] that enables analysis of weak gene promoters.
Due to the lack of cells capable of melanogenesis, we used
two well established human RPE cell lines (ARPE-19 and
D407) differing in tyrosinase mRNA expression.
METHODS
Chemicals: Cell culture media, fetal bovine serum (FBS), and
supplements  were  either  from  Invitrogen  Corporation
(Gaithersburg, MD) or Sigma (St. Louis, MO). The molecular
biology  reagents  were  from  Finnzymes  (Espoo,  Finland),
MBI  Fermentas  (Vilnius,  Lithuania),  GE  Healthcare
(Uppsala,  Sweden),  or  Promega  (Madison,  WI).
Polyethyleneimine  25  (PEI25)  and  other  reagents  of  the
highest grade available were from Sigma.
Retinal pigment epithelium and melanoma cell lines: RPE cell
lines  ARPE-19  (CRL-2302;  ATCC,  Rockville,  MD)  and
D407  [53]  were  maintained  as  previously  described  with
media  and  supplements  from  Invitrogen  [51].  G-361
melanoma  cells  (CRL-1424,  ATCC)  were  maintained  in
McCoy’s 5A medium (M8403, Sigma) supplemented with
10%  FBS,  2  mM  L-glutamine,  100  U/ml  penicillin,  and
100 μg/ml streptomycin. The ARPE-19 cells were grown at
37 °C and 7% CO2, whereas the other cells were kept at 37 °C
and  5%  CO2.  Prolonged  culture  of  G-361  or  D407  cells
beyond 96 h was not possible due to cell detachment.
Bovine and fetal human primary retinal pigment epithelium
cells: Bovine RPE cells (bRPE) were isolated [54] with minor
modifications. Briefly, bovine eyes were collected from a
local slaughterhouse. The first anterior segment, vitreous, and
neural retina were removed. Eyecup segments were quickly
washed with 1 ml 0.05% trypsin/0.5 mM EDTA (EDTA)
solution. Fresh trypsin/EDTA (1 ml) was added and incubated
for 15 min. The detached cells were transferred into a tube
containing culture medium (DMEM-F12 [Gibco Invitrogen]
supplemented with 10% FBS, 2 mM L-glutamine, 100 U/ml
penicillin, and 100 μg/ml streptomycin) and centrifuged at
390× g for 5 min. After centrifugation, the cell pellet was
suspended in 3 ml of fresh culture medium and plated onto 6-
well plates. After 3 h, the culture medium was replaced. Cells
were maintained at 37 °C and 5% CO2 in the culture medium
with  two  medium  changes  per  week.  Upon  inspection,
primary  cells  were  polygonal  containing  many  heavily
pigmented,  oval  melanosomes  that  were  lost  during
passaging. Their pigment cell origin was confirmed by the
expression of TRP-1 (data not shown). Fetal human primary
RPE cells (fhRPE) have been described [55,56]. The frozen
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39cells were thawed, and the cells were maintained at 37 °C and
5% CO2 in DMEM medium supplemented with 15% FBS
(Invitrogen) and 2 mM L-glutamine, 100 U/ml penicillin, and
100 μg/ml streptomycin, 50 µg/ml gentamicin, and 1 ng/ml
bFGF (Sigma).
RNA  isolation  and  quantitative  reverse  transcription
polymerase chain reaction: Continuous human cell lines were
seeded at high density on 6-well plates (1×106 cells per well)
to reach confluency by 48 h, and total RNA was isolated by
using TRI Reagent (Sigma). Isolated RNA was treated with
DNase  (DNA-Free  Kit,  Ambion,  Austin,  TX).  The  RNA
concentration was determined with RiboGreen quantitation
reagent (Molecular Probes, Eugene, OR). Synthesis of cDNA
(cDNA)  was  performed  by  using  M-MuLV  reverse
transcriptase (Fermentas) as reported [51]. Intron-spanning
primers for human TYR mRNA (forward 5′-AGC ACC CCA
CA AAT CCT AAC TTA C-3′ and reverse 5′-ATG GCT GTT
GTA CTC CTC CAA TC-3′), MITF-D mRNA (5′-TTT TAA
CCT GAC AGG CTT TGA ATA CAG-3′ and 5′-CAA GAT
GCG TGA TGT CAT ACT GG-3′), and MITF-H (5′-TTC
AGA TGT TCA TGC CAT GCT C-3′ and 5′-GCG TAG CAA
GAT GCG TGA T G-3′) were designed by using Primer
Express  (Applied  Biosystems,  Foster  City,  CA),  OLIGO
(Molecular  Biology  Insights,  Inc.,  Cascade,  CO)  and
BLAST programs. TaqMan primer/probe sets for MITF-A
(Hs01115553_m1), MITF-M (Hs00165156_m1), and OTX2
(Hs00222238_m1) were ordered from Applied Biosystems.
Quantitation  of  TYR,MITF-D,  and  MITF-H  mRNAs  was
performed with the SYBR Green PCR Master Mix (Applied
Biosystems)  with  final  primer  concentrations  of  100  nM.
Sequence-specific amplification of cDNAs was verified by
performing melting-point analysis. For SYBR Green PCR as
well as TaqMan PCR (TaqMan Universal PCR Master Mix,
Applied Biosystems), 40 ng of cDNA was used in the final
15 µl reaction volume. All quantitative PCRs were performed
on  an  ABI  Prism  7500  instrument  (Applied  Biosystems).
Because the β-actin (ACTB) mRNA increased during the long-
term  maintenance  of  the  APRE-19  monolayer  (data  not
shown), the threshold cycles (Ct) obtained were normalized
with  RNA  amounts  in  cDNA  synthesis,  as  instructed  by
Bustin [57].
For the fhRPE cells, the RNA was isolated and quantified
with the TaqMan Gene Expression Cells-to-CT Kit (Applied
Biosystems). The threshold cycles (Ct) were normalized to
endogenous β-actin mRNA expression. The TaqMan primer/
probe set for the human ACTB mRNA (forward 5′-CGG CAC
CAC CAT GTA CCC-3′ and reverse 5′-ACA CGG AGT ACT
TGC GCT CA-3′; probe 5′-VIC-ATC AAG ATC ATT GCT
CCT  C-MGB-3′)  was  designed  using  Primer  Express
(Applied Biosystems, Foster City, CA). Data analysis was
performed with the Q-Gene program (Equation 2) [58].
Construction  of  the  human  TYR  gene  promoter  and
mutagenesis:  The  human  TYR  promoter  fragments  were
amplified with high-fidelity PCR from human genomic DNA,
and all constructs were verified with dideoxy sequencing.
Details of the cloning are listed in Appendix 1. The established
MITF and putative OTX2 binding sites were mutated by using
the  QuickChange  II  XL  Site-Directed  Mutagenesis  Kit
(Stratagene, La Jolla, CA) according to the manufacturer’s
instructions with designed mutagenic primers (Appendix 2).
The  mutated  promoter  constructs  were  identified  with
diagnostic restriction enzyme digestions and verified with
dideoxy sequencing.
Reverse transfection of tyrosinase promoter constructs: To
assess  the  functionality  of  the  cloned  promoters,  reporter
constructs  were  delivered  into  cells  by  using  reverse
transfection on 48-well plates essentially as described [52].
Reverse transfection is an efficient gene delivery method for
hard-to-transfect  cells  such  as  primary  cells  of  the  retina
wherein  carrier/DNA  complexes  are  freeze-dried  on  the
surface of culture plates and stored for an extended time until
used for transfection. In preliminary experiments, the PEI25/
DNA charge ratio of +5 was found to give optimal transfection
efficiency and minimal cell toxicity for all cell types. The
PEI25/DNA  complexes  contained  0.5  µg  TYR  promoter-
driven  reporter,  0.5  µg  MITF-A  [38],  or  OTX2  (Origene
Technologies, Inc., Rockville, MD) expression vector, 0.2 µg
CMV  promoter-driven  pCMVβ  control  reporter,  and  an
empty pCR3 expression vector (Invitrogen) to adjust the total
DNA amount to 1.7 µg per well. The reverse transfection
plates were prepared and stored in a desiccator without any
decrease in transfection efficiency for several months [52] up
to one year (unpublished data). The thymidine kinase (TK)
promoter-driven  [51]  and  promoterless  pGL3-Basic
(Promega) reporter plasmids were used as controls in every
experiment. For transfection experiments on 48-well plates,
optimized cell numbers were used (ARPE-19: 1.2×105 and
D407: 0.5×105 cells per well). After 48 h, cells were lysed in
70 µl of lysis buffer, and lysates were assayed by using the
Victor  Multilabel  Plate  Reader  (PerkinElmer,  Turku,
Finland).  Quantitation  of  luciferase  and  β-galactosidase
(GLB1) was performed as described earlier [48] with 40 µl
and  20  µl  of  lysate,  respectively.  Reverse  transfection  of
primary fhRPE (0.65×105 cells per well, passages 4–5) and
bRPE  (0.1×105  cells  per  well,  passages  9–10)  cells  was
performed as above except that the PEI25/DNA complexes
were prepared with 1.0 µg of TYR promoter-driven reporter
and 0.4 µg of pCMVβ. High concentrations of the OTX2
expression vector may activate some viral promoters [50]. We
observed  approximately  50%  activation  of  the  pCMVβ
control reporter when cells were transfected with MITF-A or
OTX2, and less than approximately 2.7 fold activation with
their cotransfection. When the final data was processed, CMV
promoter activation was taken into account by normalizing
β-galactosidase activities with the activation factor relative to
the  empty  pCR3  vector.  In  control  experiments,  β-
galactosidase transfection efficiency was stable with less than
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4015%  variation  between  wells  transfected  with  the  same
expression constructs. All transfections were done on two or
three separate occasions with at least three replicate wells per
each condition.
Preparation of nuclear extracts and electrophoretic mobility
shift  assays:  For  electrophoretic  mobility  shift  assays
(EMSAs), oligonucleotide probes containing the wild-type
and mutated binding sites for MITF and OTX2 were designed
(Appendix  3).  Double-stranded  probes  were  labeled  with
[α-32P]dCTP (GE Healthcare and PerkinElmer) by using the
Klenow fragment (MBI Fermentas) and purified with Quick
Spin columns (GE Healthcare). The preparation of nuclear
extracts from APRE-19 cells cultured for 14 days and the
optimized  conditions  for  the  EMSA  reactions  (20  µl)  are
detailed in Appendix 1. Intensities of the specific complexes
were quantified by using Quantity One software (Bio-Rad,
Hercules, CA). Specific binding of OTX2 was demonstrated
by  performing  supershift  EMSAs.  Nuclear  extracts  from
ARPE-19 cells cultured for 14 days were incubated with the
anti-OTX2 antibody [59], or alternatively, the Flag-OTX2
expression vector (RC207479, Origene) or empty pCR3 (5 µg/
well) was reverse transfected into the D407 cells on 6-well
plates  (0.4×106  cells  per  well),  and  nuclear  extracts  were
incubated with the anti-Flag antibody (Origene).
Transient transfection of orthodenticle homeobox 2 into D407
cells: The RPE cell line D407 does not appear to express
endogenous OTX2 or tyrosinase mRNAs (see Figure 1 [48,
50]).  The  OTX2  expression  vector  (0–1.5  µg/well)  was
delivered into the D407 cells as described earlier [51] by using
conventional  transfection  with  PEI25  on  48-well  plates
(0.5×105 cells per well). Isolation of RNA, DNase treatment,
and cDNA synthesis were performed 24 h after transfection
by  using  the  TaqMan  Gene  Expression  Cells-to-CT  Kit.
Endogenous  tyrosinase  mRNA  was  quantified  and
normalized to β-actin mRNA expression as described above.
Silencing of orthodenticle homeobox and microphthalmia-
associated transcription factor mRNA expression in ARPE-19
cells with RNA interference: The role of OTX2 and MITF-A
as regulators of tyrosinase expression was studied by using
OTX2- and MITF-specific Silencer Select small interfering
RNAs  (siRNAs:  s9933,  s8790;  Ambion)  at  a  final
concentration of 25 nM. Shortly, 24 h after plating on 48-well
plates  (0.75×105  cells  per  well)  the  ARPE-19  cells  were
transfected  with  the  TransIT-TKO  Transfection  Reagent
(Mirus,  Madison,  WI)  according  to  the  manufacturer’s
instructions.  RNA  isolation,  DNase  treatment,  and  cDNA
synthesis were performed 48 h after transfection by using the
TaqMan Gene Expression Cells-to-CT Kit. Silencer Select
Negative Control #1 siRNA (Ambion) was used to monitor
the effects of siRNA delivery in each experiment. Endogenous
TYR,  OTX2,  and  MITF-A  mRNAs  were  quantified  and
normalized to ACTB mRNA expression as described above.
Yeast two-hybrid assay: To study potential protein–protein
Figure 1. Expression of TYR, MITF-A, MITF-D, MITF-H, MITF-
M, and OTX2 mRNA in RPE cells. ARPE-19 mRNA was collected
at various time points (6 h, 24 h, 48 h, 96 h, 14 days, and 30 days).
Other samples were isolated at 96 h from D407 RPE cells and G-361
melanoma cells, a positive control for TYR expression. Results are
presented as the mean normalized expression±SD relative to 6 h
ARPE-19 culture (=1) from three to four independent cultures each
performed in triplicate. Due to very low expression levels, MITF-D
values  were  normalized  relative  to  MITF-H  (6  h  ARPE-19
culture=1).
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41interactions  between  the  OTX2  and  MITF  transcription
factors, constructs coding for full-length proteins (or reported
functional  domains  thereof)  were  created  by  using  the
pGBKT7 and pGADT7 plasmids within the yeast two-hybrid
system (Matchmaker GAL4 System 3, Clontech Laboratories
Inc., Mountain View, CA). Desired sequences were amplified
from the OTX2, MITF-A, or MITF-M [34] expression vector
by  using  the  high-fidelity  Phusion  DNA  polymerase
(Finnzymes)  and  sequence-specific  primers  (primer
sequences available upon request). Amplified MITF-A and
MITF-M  products  were  digested  with  NdeI  and  SalI  and
cloned into the NdeI/SalI-digested pGBKT7 GAL4 DNA-
binding  domain  vector,  resulting  in  yeast  “bait”  vectors
coding for full-length MITF-A (FL: residues 1−520) or its
fragments  (A1−AD:  residues  1−297,  A1−B1b:  residues
1−124, B1b−AD: residues 36−297, AD: residues 118−297),
or MITF-M (FL: residues 1−419, M1−AD: residues 1−196).
The common central and C-terminal domains of MITF-A and
MITF-M  isoforms  were  cloned  into  pGBKT7  vectors  by
NdeI/SalI digestions to produce fragment constructs (bHLH-
LZ:  MITF-A  residues  295−405,  S:  MITF-A  residues
402−520).  Amplified  OTX2  products  were  digested  with
EcoRI and BglII and cloned into the EcoRI/BglII-digested
pGADT7 vector that resulted in yeast “prey” vectors encoding
the full-length OTX2 (FL: residues 1−297) or its fragments
(ND:  residues  1−37,  HD:  residues  37−109,  CD:  residues
107−297) fused to the GAL4 activation domain. As a positive
control,  the  established  bait/prey  interaction  between  the
mouse  constitutive  androstane  receptor  ligand-binding
domain (mCAR in pGBKT7) and the mouse steroid receptor
coactivator-1 peptide (mSRC-1 in pGADT7) was used [60].
The yeast transformations and β-galactosidase assays were
performed according to the manufacturers’ instructions.
RESULTS
In  ARPE-19  cells,  levels  of  tyrosinase  and  orthodenticle
homeobox 2 mRNAs increase in parallel: Amelanotic human
ARPE-19 cells are commonly used as a model for pigmented
RPE cells [61]. Tyrosinase mRNA was upregulated already
at 48 h, reaching more than a 300-fold increase at extended
culture for 14–30 days (Figure 1, top panel). These levels
exceed those in G-361 melanoma cells while another RPE cell
line  D407  lacking  pigmentation  [53]  did  not  express
tyrosinase mRNA. ARPE-19 cells can be maintained as a
monolayer  for  extended  periods  due  to  the  cells’  contact
inhibition  [61],  while  for  D407  and  G-361  cells,  cell
detachment  precluded  reliable  mRNA  quantification  in
cultures exceeding 96 h. The transcription factor MITF-A
mRNA  was  expressed  at  remarkably  constant  levels
(≤twofold differences) during the first 96 h after which it
increased 17 to 36 fold. The MITF-A mRNA was present at
even higher levels in tyrosinase-expressing G-361 cells and
D407 cells devoid of TYR mRNA (second panel). MITF-D
mRNA was expressed in ARPE-19 cells at very low levels,
reaching the highest activity during the extended cultures of
14–30 days (third panel) while it was not expressed in D407
or G-361 cells. In contrast, MITF-H mRNA was expressed in
both types of RPE cells, shared a similar expression pattern
with MITF-A, and reached more than a 300 fold increase at
14–30 days (fourth panel). The ARPE-19 cells expressed low
levels  of  MITF-M  mRNA  with  10  to  15-fold  increases
occurring upon extended culture. MITF-M mRNA was also
present in D407 cells and at high levels in G-361 cells, as
expected (fifth panel). In contrast to the MITF factors, the
OTX2 mRNA was upregulated threefold already at 48 h in the
ARPE-19 cells, reaching an 18-fold increase at 14 days. The
G-361 and D407 cells did not express OTX2 mRNA (Figure
1, bottom panel). In summary, upregulation of OTX2 and
TYR  mRNAs  precedes  the  enhanced  expression  of  MITF
transcripts in ARPE-19 cells, and high levels of MITF-A,
MITF-H,  and  MITF-M  are  not  sufficient  to  trigger  TYR
expression in D407 cells. These temporal and cell-dependent
results prompted us to study the association of OTX2 and
TYR gene expression in more detail.
Activities of the human tyrosinase promoter constructs in
retinal  pigment  epithelium  cells:  To  determine  the  DNA
elements involved in basal and transcription factor-mediated
expression, we cloned several fragments of the human TYR
promoter (−1995/+74) carrying the established MITF binding
sites M box (−104), E box (−12), or TDE (−1861) and distal
regions  most  homologous  to  the  mouse  TYR  gene
(−9860/-8741 and −2525/-1996) upstream of the luciferase
reporter (Figure 2, top). We transfected ARPE-19 cells with
these reporter constructs together with empty, MITF-A, or
OTX2  expression  vectors,  and  cultured  them  for  48  h.
Transfection of either MITF-A or OTX2 resulted in more than
30 fold enhancement of the respective transcription factor
mRNA, with no discernible effect on the expression of the
reciprocal  factor  (data  not  shown).  During  the  DNA
transfection period, the endogenous OTX2 and TYR mRNAs
displayed a slight increase while the MITF mRNAs remained
stable (Figure 1). During the same time, the basal reporter
activities of the TYR promoter in ARPE-19 were low but
clearly detectable (Figure 2, white columns), and deletion of
the enhancer and TDE barely decreased the activity. The
D407 cells gave similar results (Appendix 4). In the ARPE-19
cells, approximately threefold upregulation by MITF-A of
reporter activity required the proximal DNA region −152/+74
that carried M and E boxes (Figure 2, gray columns). In the
D407 cells, the activation by MITF-A was significant (>2
fold) with −462 or longer constructs (Appendix 4). In contrast
to the modest effects of MITF-A in ARPE-19 cells, OTX2
activated the longer reporter constructs robustly (19 to 26 fold;
Figure 2, hatched columns). The bulk of the OTX2-dependent
activity resided in the fragment −462/-153, and the proximal
promoter −152/+74 still mediated approximately threefold
activation. The results with the D407 cells were rather similar
to those of the ARPE-19 cells (Appendix 4). Thus, OTX2 can
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42upregulate the TYR gene promoter in RPE cells to a much
higher degree than MITF-A.
The  relative  importance  of  microphthalmia-associated
transcription factor-A and orthodenticle homeobox 2 binding
sites in the human tyrosinase proximal promoter: We next
focused on the fragment −462/+74, which contained the most
important  elements  for  OTX2  and  MITF-A  responses  in
ARPE-19 cells. Three motifs similar to the OTX2 binding site
TAATCY [62] were found at positions −361, −354, and −226,
upstream of the M (−102) and E boxes (−12; Appendix 2 and
Appendix  3).  The  effects  of  MITF-A  or  OTX2  or  their
combination on these proximal TYR promoters carrying either
wild-type or mutated MITF binding sites are shown in Figure
3A. Mutagenesis of the M box decreased the basal (white
columns) and MITF-A-dependent (gray columns) promoter
activities  in  ARPE-19  cells  by  approximately  50%  while
mutation of the E box had no discernible effect. Disruption of
MITF sites and the M box alone decreased the trans-activation
by OTX2 markedly (hatched columns; from 13- to sevenfold),
even though OTX2 binding sites 1 to 3 were intact in the
−462  construct.  MITF-A  and  OTX2  activated  the  −152
construct by approximately 2.5 fold, but surprisingly, their
cotransfection was synergistic (20 fold; black columns) even
in the absence of any OTX2 binding sites. In the D407 cells
(Appendix 5), the results recapitulated the effects seen in the
ARPE-19 cells, i.e., activation by OTX2 depended partially
on the M box, and synergism was observed with the −152
construct. Taken together, the M box is most important for
MITF-A’s control of the TYR promoter in ARPE-19 cells.
Moreover, OTX2 acts directly via OTX2 binding sites and
indirectly via MITF sites, preferentially the M box.
Next, the putative OTX2 binding sites were mutated and
reporter activities analyzed in a similar fashion (Figure 3B).
In  the  ARPE-19  cells,  none  of  the  OTX2  site  mutations
decreased basal or MITF-A-dependent activities (white and
gray columns). The OTX2-dependent activity was decreased
by all mutations (hatched columns), although most sensitively
by mutation at site 3. Mutation of all OTX2 sites (construct
−462m123) reduced the OTX2-dependent activity by 65%,
and the remaining threefold activation was dependent on the
MITF binding sites. The synergistic activation by MITF-A
and OTX2 was slightly reduced by OTX2 site mutations, with
the largest decrease (45%) seen again with the mutation at site
3. Similar results were obtained with D407 cells (Appendix
6). Thus, binding site 3 is the major determinant of direct
OTX2 activation in ARPE-19 cells.
A functional single nucleotide polymorphism is located in
orthodenticle homeobox 2 binding site 3: Comparison of the
promoter  sequence  with  the  National  Center  for  Biologic
Information  Single  Nucleotide  Polymorphism  database
(Table 1) indicated that a single nucleotide polymorphism
(SNP; rs4547091, T/C at −223) was located within the OTX2
binding site 3. The frequency of this SNP varies dramatically,
with individuals of African ancestry carrying mostly the T/T
genotype (73.9%) while individuals of European or Asian
ancestry have a preponderance of the C/T (45.5%) or C/C
(63.6%) genotype, respectively. The T-223C mutation was
introduced  into  the  long  and  proximal  TYR  promoter
constructs (Figure 4A and Appendix 7). We found that this
SNP decreased OTX2-dependent activities (hatched columns)
by up to 74%, and with the −462 construct, the effect of the
SNP was practically equal to the disruption of site 3. The
synergistic effect of MITF-A and OTX2 was also decreased
by up to 61% (black columns). To study these findings in a
more natural setting, we transfected the wild-type and SNP-
carrying reporter constructs into primary bovine and fetal
human  RPE  cells.  Although  the  primary  cells  replicated
slower and their transfection efficiencies were lower than for
the RPE cell lines, the SNP reduced the reporter activities in
primary bovine cells (Figure 4B) and in fetal human primary
RPE  cells  (Figure  4C).  The  latter  cells  also  expressed
Figure 2. OTX2 activation of the human
TYR promoter is mediated through the
proximal region at −462 to −152. Luc-
reporter  constructs  containing  the
human  TYR  promoter  −2525  with
enhancer  element  −9860  to  −8741
(=Enh./-2525), deletions −2525, −1995,
−462,  −152,  and  promoterless  pGL3-
Basic were cotransfected into ARPE-19
cells with MITF-A, OTX2, or an empty
expression vector (pCR3). Normalized
luciferase activities are relative to the
TYR  promoter  construct  −152  (=1)
cotransfected with the empty expression
vector  (pCR3).  Data  are  means
±standard error of the mean (SEM) from
two  independent  transfections  each
performed in triplicate.
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43endogenous tyrosinase, MITF-A, and OTX2 mRNAs (Figure
4D). In summary, transcription of the TYR gene in RPE cells
might be affected by genetic differences in the OTX2 binding
site 3 among individuals.
Specific nuclear proteins bind to orthodenticle homeobox 2
and microphthalmia-associated transcription factor-A sites
in ARPE-19 cells: Human nuclear protein binding to TYR
promoter elements in RPE cells has never been studied before,
and DNA binding has been assessed only with recombinant
proteins in vitro [35,49]. Because TYR regulation may involve
post-translational  modification  absent  in  the  recombinant
MITF and OTX2 proteins, we prepared nuclear extracts from
14-day  ARPE-19  cell  cultures  (when  MITF-A  and  OTX2
mRNAs are expressed and the TYR gene is activated), and
Figure 3. OTX2 can activate the human
TYR promoter even in the absence of
DNA  binding  sites.  OTX2  directly
activates  the  TYR  promoter  through
specific OTX2 binding sites 1 (−361 to
−356), 2 (−354 to −349) and 3 (−226 to
−221) and indirectly via MITF sites. A:
Luc-reporter  constructs  containing
disrupted  MITF  binding  sites  at
positions −104 to −99 (mM=mutation of
the M box) and −12 to −7 (mE=mutation
of the E box). B: Disruptions of OTX2
binding sites 1, 2, and/or 3 (renamed m1,
m2,  and  m3)  in  the  human  TYR
promoters  −152  or  −462  were
cotransfected into ARPE-19 cells with
MITF-A  or  OTX2  factors,  their
combination,  or  with  an  empty
expression vector (pCR3). Normalized
luciferase activities are relative to TYR
promoter  construct  −152  (=1)
cotransfected with the empty expression
vector pCR3 (=vector only). Data are
means±SEM  from  two  independent
transfections  each  performed  in
triplicate.
TABLE 1. THE FREQUENCY OF SNP RS4547091 IN DIFFERENT HUMAN POPULATIONS.
Population Allele frequencies
  C/C C/T T/T
African American 0.043 0.217 0.739
European 0.273 0.455 0.273
Asian 0.636 0.273 0.091
Fold activation by OTX2 in ARPE-19 cells Genotype in construct
  C/C   T/T
Enh/-2525 construct 19.7 (55%)   36.0 (100%)
−462 construct 6.7 (26%)   25.8 (100%)
         The frequency data for the SNP ID rs4547091 (T to C) at location chromosome 11, position 8855046 were retrieved from the
         NCBI SNP database (rs4547091). The reporter activity data was derived from Figure 4A.
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44DNA binding and competition experiments were performed
under optimized conditions. Because the OTX2 sites 1 and 2
are very close to each other, we used a probe covering both
sites and observed two main complexes (Figure 5A). The
upper complex A was highly specific, because it could be
competed by only a sixfold excess of unlabeled probes for
OTX2 sites 1 and 2 or site 3. The competition was less efficient
by probes containing single mutations at site 1 or 2, and little
or no competition was detected by an unrelated probe, the
double mutant 1 and 2 probe, and when site 3 was mutated or
carried the SNP. The lower complex B was non-specific. We
detected  a  more  intricate  pattern  with  the  OTX2  probe  3
(Figure  5B).  At  least  three  specific,  slowly  migrating
complexes (A1 to A3) were competed by only a sixfold excess
of unlabeled OTX2 probe 3 but not when the site 3 was
mutated or contained the SNP. Partial competition of the A1
complex was observed with the wild-type probes 1 and 2 but
not  when  these  OTX2  sites  were  mutated.  In  addition,  a
diffuse and fast-migrating doublet complex C was competed
in  a  similar  fashion  to  complexes  A1–A3.  When  the
specificity of OTX2 binding was studied with the supershift
assay (Figure 5C), the formation of complex C was inhibited
by the OTX2-specific antibody [59]. When D407 cells were
transfected with the Flag-OTX2 plasmid, we found a great
increase in the intensity of complex C and a supershift by the
anti-Flag antibody (Figure 5D). With the MITF M box and E
box  probes  (Appendix  8),  we  detected  single  specific
complexes A and A1, respectively, which were competed out
only by wild-type but not by mutated M or E box or unrelated
probes. Therefore, specific binding proteins for MITF-A and
OTX2  sites  exist  in  ARPE-19  cell  nuclei.  The  effects  of
mutations on DNA binding correlated remarkably well with
the cotransfection assays: especially, the SNP at OTX2 site 3
attenuated nuclear protein binding and reporter activation.
Expression of orthodenticle homeobox 2 activates tyrosinase
mRNA expression in D407 cells: Because the RPE cell line
D407  expresses  MITF-A  but  lacks  OTX2  and  tyrosinase
mRNAs (Figure 1), it was possible to test whether forced
expression of OTX2 is sufficient to activate the TYR gene.
After transfection into D407 cells and culture for 24 h (Figure
6A), OTX2 upregulated tyrosinase mRNA dose-dependently,
from undetectable levels to more than a 100-fold increase.
This  suggests  strongly  that  OTX2  is  necessary  for  TYR
expression in RPE cells.
TYR expression in ARPE-19 cells is suppressed by specific
small interfering RNAs against orthodenticle homeobox 2 and
microphthalmia-associated transcription factor: The above
experiments imply that control of the human TYR expression
Figure 4. A SNP in the OTX2 binding
site 3 decreases the activity of the human
TYR  promoter.  A–C:  The  T-223C
(rs4547091) mutation (marked here as
SNP)  was  introduced  to  reporters
containing the TYR promoter fragments
Enh./-2525  and  −462.  The  wild-type
and mutated reporters and −462m3 or
−462m123  plasmids  were  transfected
into  ARPE-19,  bovine  (bRPE),  and
human fetal primary RPE (fhRPE) cells
with  MITF-A  or  OTX2  factors,  their
combination,  or  an  empty  expression
vector (pCR3). Data are means±SEM
from  two  independent  transfections
performed in triplicate or quadruplicate.
D:  The  endogenous  expression  of
tyrosinase, MITF-A, and OTX2 mRNA
in fhRPE cells was measured at time
point 48 h. Mean normalized expression
±SEM  are  shown  relative  to  48  h
ARPE-19  culture  (=100)  from  two
independent cultures each performed in
triplicate.
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45Figure 5. Specific nuclear protein binds to OTX2 binding elements
in the human tyrosinase promoter. ARPE-19 cells were cultured for
14 days, and nuclear extracts were prepared. Binding of nuclear
proteins to labeled OTX2 probes 1 and 2 (A) and 3 (B) was competed
with only a sixfold excess of unlabeled probes for unrelated GAL4
(lanes 3), wild-type or mutated OTX2 sites 1 and 2 (lanes 4–7), wild-
type or mutated OTX2 site 3 (lanes 8–9), and SNP rs4547091 at
OTX2 site 3 (lanes 10). Complexes showing specific DNA-nuclear
protein interaction are indicated with the symbol A, A1, A2, A3, or
C. Non-specific DNA-nuclear protein complexes are indicated with
B. Free probes in the absence of nuclear extracts are on lanes 1, and
full reactions without competitor are on lanes 2. Above the gel
images,  intensities  of  the  most  specific  DNA  nuclear  protein
complexes A (A) and A1 (B) are shown relative to nuclear extracts
without competitor (lanes 2=100). C: Supershift assay of OTX2
binding site 3 was performed by incubating nuclear extracts from
ARPE-19 cells with or without the OTX2 antibody. Strong and
modest inhibition of the specific complexes C1 and C2, respectively,
was observed. D: D407 cells were transfected with the Flag-tagged
OTX2 cDNA or with empty control plasmid (pCR3), and nuclear
extracts  were  prepared  and  incubated  with  the  Flag-specific
antibody. The supershifted DNA–protein complex is indicated with
the symbol S. Both supershift assays were controlled by using a non-
specific control antibody (data not shown).
Figure 6. Modulation of OTX2 levels in RPE cells results in parallel
expression of tyrosinase mRNA. A: Various amounts (0 to 1.5 µg)
of  OTX2  expression  plasmid  were  transfected  into  D407  cells
followed by measurement of tyrosinase mRNA expression. Results
are presented as the mean normalized expression±SEM relative to
maximal OTX2 expression plasmid amount (1.5 µg=100) from three
independent  transfections  each  performed  in  triplicate.  B:
Endogenous tyrosinase, OTX2, and MITF-A mRNA levels were
determined  48  h  after  transfection  of  OTX2-  or  MITF-specific
siRNA  into  ARPE-19  cells.  Results  are  presented  as  the  mean
normalized expression±SD relative to cells transfected with non-
specific siRNA (=100) from three independent transfections each
performed in triplicate.
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46is mediated by OTX2 and MITFs. To confirm this, we reduced
the expression of endogenous OTX2 and MITF with RNA
silencing (Figure 6B). The TYR, OTX2, and MITF-A mRNA
expression levels were decreased up to 63%, 61%, and 39%,
respectively, with OTX2 siRNA transfection. When MITF
siRNA was used, the TYR and MITF-A mRNA levels were
decreased  up  to  56%  and  48%,  respectively,  whereas  the
OTX2 levels were slightly increased. Despite the siRNAs’
moderate  silencing  efficiency,  suppression  of  both
transcription  factors  clearly  reduced  tyrosinase  mRNA
expression.
Orthodenticle homeobox 2 and microphthalmia-associated
transcription factor transcription factors interact physically:
Because OTX2 can indirectly enhance TYR expression via the
MITF sites (Figure 3), a potential interaction between OTX2
and MITF-A is implied. To study this interaction, we used the
yeast two-hybrid assay and the modular structure of these two
factors.  MITF-A  contains  two  distinct  trans-activation
domains (AD and S fragments) and a central DNA-binding
domain  encoded  by  the  bHLH-LZ  fragment  [63].  OTX2
contains a DNA-binding homeodomain (HD) flanked by two
trans-activation  domains  [62],  termed  here  ND  and  CD
(Figure 7A). In the yeast two-hybrid assays, we found high
β-galactosidase reporter activities with the full-length MITF-
A as bait and the full-length OTX2 as prey (Figure 7B, gray
columns).  Upon  investigating  various  MITF-A  bait
fragments,  the  interaction  required  the  presence  of  both
activation domains (constructs containing domains AD or S)
when  the  background  activity  of  OTX2  alone  (hatched
columns)  was  taken  into  account.  Among  the  MITF-A
fragments, only the N-terminal A/B1b/AD domain displayed
any  substantial  autoactivation  of  the  reporter  (Figure  7B,
white columns). The MITF-A regions that showed reporter
activity above the OTX2 prey alone were then individually
tested  for  interactions  with  the  full-length  OTX2  and  its
subdomains. We saw generally modest reporter activities by
MITF-A  fragments  with  either  N-  and  C-terminal  trans-
activation domains of OTX2. These activities were close to
the autoactivation values of the OTX2 domains (Figure 7C,
white columns). Instead, the DNA-binding homeodomain of
OTX2 interacted with MITF-A activation domains AD and S,
which supports the idea of physical interaction between the
OTX2 and MITF-A transcription factors.
Because ARPE-19 cells expressed MITF-A and MITF-
M  mRNAs  (Figure  1)  possessing  common  and  isoform-
specific domains (Figure 8A), we investigated whether the
functions  of  the  MITF  isoforms  were  similar.  Full-length
MITF isoforms recruited OTX2 to a similar extent, while the
N-terminal activation domain of MITF-M yielded a lower
response  than  that  of  MITF-A  (Figure  8B).  In  transient
transfections with the construct −152 carrying the MITF but
no OTX2 sites (Figure 8C), OTX2 and MITF-A activated the
reporter by approximately 6.5-fold while MITF-M yielded a
fourfold  response.  The  synergism  with  OTX2  by  the  M
Figure  7.  Protein–protein  interactions  occur  between  OTX2  and
MITF-A. A: Full-length (FL) MITF-A and OTX2 and their known
domains are shown with the corresponding amino acids as follows:
MITF-A  specific  N-terminal  (A),  N-terminal  region  common  in
MITF-A and several other isoforms (B1b), activation domain (AD),
basic helix–loop–helix leucine zipper (bHLH-LZ), and serine-rich
C-terminal  activation  domain  (S);  OTX2  DNA-binding
homeodomain (HD); and N- and C-terminal activation domains (ND,
CD). B: Interactions of full-length OTX2 with various MITF-A
domains (FL: aa1–520; A-B1b-AD: aa1–297; A-B1b: aa1–124; B1b-
AD: aa36–297; AD: aa118–297; bHLH-LZ: aa295–405 or S: aa402–
520) are shown by gray columns. Auto-activation of each “bait”
MITF-A domain alone is indicated by white columns and for the full-
length  OTX2  “prey”  construct  by  the  hatched  column.  C:
Interactions of selected MITF-A domains (FL, A-B1b-AD, AD, or
S) with various OTX2 domains (FL: aa1−297; ND: aa1−37; HD:
aa37−109 or CD: aa107−297) were assessed (gray columns) and
compared with empty “bait” vectors (white columns). Assays were
controlled with the yeast strain carrying empty “bait” and “prey”
vectors  or  the  positive  control  mCAR/SRC1  (black  columns).
Results are means±SEM relative to the maximal activation of the β-
galactosidase reporter (=100) from three independent assays each
performed in quadruplicate..
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47isoform was about 1.7-fold greater than by MITF-A. The
reporter with mutated MITF M and E boxes was not activated
by any of the factors. Collectively, our data show that isoforms
A and M can associate with OTX2 and synergize to activate
the human TYR gene promoter.
DISCUSSION
In this study, we provide novel mechanisms for regulating the
human TYR gene, and emphasize the role of OTX2 in the RPE.
These findings might also contribute to understanding the role
of OTX2 in regulating other MITF-controlled genes [64,65]
in  the  RPE.  Finally,  we  discuss  the  significance  of  the
discovered  functional  SNP  on  the  TYR  expression  and
pathophysiology of the RPE.
An important role for OTX2 in human TYR regulation
emerges from the following findings. First, the upregulation
of TYR mRNA parallels the increase in OTX2 expression and
precedes that of MITF isoforms, and OTX2- or MITF-specific
siRNAs suppress TYR mRNA levels in ARPE-19 cells. Even
though OTX2 and MITF siRNAs were able to only partially
downregulate their cognate targets by 50% to 60%, the TYR
mRNA  level  decreased  to  the  same  extent  (60%).  This
indicates  a  strong  regulatory  linkage  between  the  human
TYR promoter, MITF, and OTX2. Second, despite the presence
of MITF-A and -H, TYR mRNA is expressed in D407 cells
only after forced expression of OTX2. Moreover, the RPE-
specific MITF-D was not expressed in D407 cells, and its role
in TYR expression remains to be elucidated. Third, OTX2 can
activate the TYR proximal promoter in ARPE-19 cells to much
higher levels than MITF-A or MITF-M alone. The OTX2-
dependent activation occurs via direct binding to the distal
OTX2 sites and via indirect protein interaction at the proximal
MITF sites.
This  novel  indirect  activation  is  profoundly  different
from what Martinez-Morales and coworkers reported for the
mouse QNR71 promoter [49]. They demonstrated that intact
OTX2 sites within the mouse QNR71 promoter are obligatory
for synergistic trans-activation by OTX2 and MITF, but they
did not study the mouse TYR promoter in detail [49]. Our study
shows  clearly  that  OTX2  can  activate  the  human  TYR
promoter, in the absence of any OTX2 binding elements, via
MITF  sites  at  the  very  proximal  part  of  the  promoter.
Constructs lacking OTX2 sites 1 to 3 but harboring the M box
had  high  levels  of  OTX2-dependent  activity  suggesting
protein–protein interactions between factors binding to these
closely  spaced  elements.  The  intricate  pattern  of  nuclear
protein binding at OTX2 site 3 is consistent with protein
complexes that could represent OTX2, OTX2 dimers, and/or
OTX2 in complex with MITF isoforms. Further, binding of
OTX2 to site 3 was shown in supershift assays with specific
antibodies.  Next,  we  demonstrated  a  robust  physical
interaction between the full-length proteins that was mediated
by the OTX2 homeodomain and the trans-activation domains
of MITF. Our results contrast with the interaction detected in
Figure 8. Effects of the MITF isoforms A and M are comparable.
A:  Full-length  (FL)  MITF  isoforms  A  and  M  and  their  known
domains are shown with the corresponding amino acids: MITF-A
domains A, B1b, and AD, common domains bHLH-LZ and S, and the
MITF-M specific N-terminal region (M). Additional six amino acids
of the M isoform (aa187–192) are shown. B: Interactions of the full-
length OTX2 and domains from the MITF isoform A (FL: aa1–520;
A-B1b-AD: aa1–297) or M (FL: aa1–419; M-AD: aa1–196) were
measured and are shown with gray columns. The level of MITF auto-
activation is indicated by white columns. Assays were performed as
in Figure 7 from three independent experiments each performed in
quadruplicate.  C:  ARPE-19  cells  were  cotransfected  with  the
proximal TYR promoter lacking any OTX2 sites but with intact
(−152: black columns) or mutated MITF binding sites (−152mMmE:
gray columns). Normalized luciferase activities are relative to TYR
promoter  construct  −152  (=1)  cotransfected  with  the  empty
expression vector pCR3 (=no TF). Data are means±SEM from two
independent transfections each performed in triplicate.
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48vitro  between  the  recombinant  full-length  OTX2  and  the
bHLH domain of MITF [49]. However, both studies showed
a direct interaction between OTX2 and MITF, and “bridging”
factors are not necessary to explain the synergism in trans-
activation or the EMSA band patterns. Redundancy in the
interaction  of  OTX2  with  MITF  isoforms  A  and  M  also
supports the finding that activation of the mouse TYR gene
does not depend on the N-terminal structure of the MITF
isoforms [37]. On a related note, both types of RPE cells
displayed high activity when they were cotransfected with
reporter constructs carrying enhancer and TDE elements. This
suggests  potential  long-range  interactions  of  OTX2  with
MITF bound also at these distal locations [35,66].
Thus, a major role for OTX2 emerges in the regulation of
TYR expression in human RPE cells. This view is supported
by several knockout mouse models. First, mouse Otx2−/− or
Otx2+/−  embryos  have  abnormally  developed  eyes  [39].
Second, the loss of Otx2 disturbs the wingless (Wnt)/β-catenin
pathway [41], which is necessary for the RPE phenotype,
melanogenesis,  and  the  response  to  oxidative  stress  [28].
Third, in Otx2+/− mice, expression of Mitf and TYR genes is
reduced and restricted to a few Otx2-positive cells [39]. Very
recently, studies on conditional knockdown mice [67,68] have
shown that elimination of OTX2 decreases melanogenesis and
pigmentation of the RPE, culminating in degeneration of the
retina. This correlates nicely with our findings on the role of
OTX2 in regulating TYR and its relevance in vivo. Moreover,
some OTX2 targets that control tyrosinase activity and sorting
such as TRP-2 are also on the “human RPE signature gene
list” [69].
We report here the presence of a functional SNP in the
human  TYR  promoter  that  enforces  the  role  of  OTX2.
Although the presence of tyrosinase activity in the adult RPE
is  controversial,  the  TYR  gene  is  highly  active  in  the
developing eye [70]. Reduced melanogenesis in early life may
have far-reaching functional effects on the aging RPE, and
accordingly,  fetal  human  RPE  cells  exhibited  decreased
reporter  activity  with  the  T-223C  mutation.  Certain  RPE
diseases such as age-related macular degeneration are linked
to  radiation  or  oxidative  damage  and,  thus,  inversely
correlated with protection by melanin [6]. The prevalence of
age-related  macular  degeneration  is  associated  with  RPE
depigmentation [71,72] and less frequent among persons of
African  descent  [73–75].  These  phenotypes  are  therefore
consistent with the OTX2 and the polymorphic site 3 having
a significant role in tyrosinase and melanin production in the
RPE. The view that common polymorphisms associated with
common traits are likely to be located in regulatory elements
of the gene [75], as exemplified by the vitamin K epoxide
reductase complex 1 (VKORC1) gene [76], are also in line
with our conclusions. Therefore, it would be interesting to
study the association of this SNP with levels of RPE melanin
or with other RPE diseases in human subjects.
In addition, due to the expression of OTX2 in the central
nervous tissue [42], and the presence of tyrosinase in the
substantia nigra and other parts of the brain [77], the question
of  the  role  of  OTX2  and  the  polymorphic  site  3  in
susceptibility  to  Parkinson  disease  arises.  Depigmentation
and/or loss of pigmented cells in the substantia nigra and the
locus ceruleus are typical findings in Parkinson disease [78–
81], and epidemiological studies have shown variation among
ethnic groups in the prevalence of Parkinson disease [82].
However,  the  regulation  of  neuromelanin  biosynthesis  in
pigmented neurons is unclear and requires further study. In
conclusion, our findings clearly warrant further studies on the
interplay of OTX2 and MITF and on the genetic variation
associated with human TYR gene regulation in the retina and
other pigmented cells.
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52Appendix 1.
Supplemental methods. Cloning of the human tyrosinase
promoter  and  construction  of  promoter  deletions;  and
Preparation  of  nuclear  extracts  and  EMSA  reactions.  To
access the data, click or select the words “Appendix 1.” This
will initiate the download of a compressed (pdf) archive that
contains  the  file.  Complementary  antisense  primers  for
mutagenesis are not shown. Mutated nucleotides are shown
with  capital  letters  and  the  positions  of  binding  sites  are
underlined.
Appendix 2.
Sense primers for the site-directed mutagenesis of MITF
and OTX2 transcription factor binding sites. To access the
data, click or select the words “Appendix 2.” This will initiate
the download of a compressed (pdf) archive that contains the
file. Complementary antisense primers for mutagenesis are
not shown. Mutated nucleotides are shown with capital letters
and the positions of binding sites are underlined.
Appendix 3.
Sense oligonucleotides for the electrophoretic mobility
shift assays. To access the data, click or select the words
“Appendix 3.” This will initiate the download of a compressed
(pdf)  archive  that  contains  the  file.  The  positions  of  the
binding elements are underlined and mutated nucleotides are
in capital letters. For each oligonucleotide, four unspecific
nucleotides at the 5′-end were designed for fill-in labeling with
[α-32P] dCTP. Complementary antisense sequences are not
shown.
Appendix 4.
OTX2  activates  the  tyrosinase  promoter  through  the
proximal region at −462 to −152. To access the data, click or
select the words “Appendix 4.” This will initiate the download
of a compressed (pdf) archive that contains the file. Luc-
reporter constructs containing the human tyrosinase promoter
−2525 with enhancer element −9860 to −8741 (=Enh./-2525),
deletions −2525, −1995, −462, −152 and promoterless pGL3-
Basic were cotransfected into D407 RPE cells with MITF-A,
OTX2  or  empty  expression  vector  (pCR3).  Normalized
luciferase  activities  are  relative  to  tyrosinase  promoter
construct −152 (=1) co-transfected with empty expression
vector (pCR3). Data are means±SEM from two independent
transfections performed in triplicate.
Appendix 5.
In the RPE, OTX2 activates the tyrosinase promoter in
the absence of MITF binding elements. To access the data,
click or select the words “Appendix 5.” This will initiate the
download of a compressed (pdf) archive that contains the file.
Luc-reporter  constructs  containing  deletions  of  the  MITF
binding elements at positions −104 to −99 (mM=deletion of
the M-box) and −12 to −7 (mE=deletion of the E-box) in the
human  tyrosinase  promoters  −152  or  −462  were  co-
transfected into D407 cells with MITF-A, OTX2, MITF-A/
OTX2  factors  or  with  empty  expression  vector  (pCR3).
Normalized  luciferase  activities  are  relative  to  tyrosinase
promoter  construct  −152  (=1)  co-transfected  with  empty
expression vector pCR3 (=vector only). Data are means±SEM
from two independent transfections performed in triplicate.
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53Appendix 6.
OTX2  activates  the  tyrosinase  promoter  through  the
specific OTX2 binding elements 1 (−361 to −356), 2 (−354 to
−349) and 3 (−226 to −221) and through the protein–protein
interactions with MITF. To access the data, click or select the
words “Appendix 6.” This will initiate the download of a
compressed (pdf) archive that contains the file. Luc-reporter
constructs containing deletions of the OTX2 binding elements
1, 2 and/or 3 (renamed as m1, m2 and m3) in the human
tyrosinase promoter −462 were co-transfected into D407 cells
with MITF-A, OTX2, MITF-A/OTX2 factors or with empty
expression vector (pCR3). Normalized luciferase activities
are relative to tyrosinase promoter construct −152 (=1) co-
transfected with empty expression vector pCR3 (not shown).
Data are means±SEM from two independent transfections
performed in triplicate.
Appendix 7.
SNP (rs4547091) in OTX2 binding element 3 (−226 to
−221) decrease the activity of the human tyrosinase promoter
dramatically in the presence of OTX2 and MITF-A. To access
the data, click or select the words “Appendix 7.” This will
initiate  the  download  of  a  compressed  (pdf)  archive  that
contains  the  file.  Lucreporter  construct  containing  the
tyrosinase promoter fragments Enh./-2525, Enh./-2525SNP,
−462, −462SNP or −462m3 were co-transfected into D407
RPE cells with MITF-A, OTX2, MITF-A/OTX2 factors or
with empty expression vector (pCR3). Normalized luciferase
activities are relative to tyrosinase promoter construct −152
(=1) co-transfected with empty expression vector pCR3 (not
shown).  Data  are  means±SEM  from  two  independent
transfections performed in triplicate.
Appendix 8.
Nuclear  protein  binding  to  proximal  MITF  binding
elements in the human TYR promoter. Nuclear protein binding
to M-box and E-box binding elements was studied by using
double-stranded  DNA  probes  and  nuclear  extracts  from
ARPE-19 cells cultured for 14 days. To access the data, click
or  select  the  words  “Appendix  8.”  This  will  initiate  the
download of a compressed (pdf) archive that contains the file.
Top panel, labeled M-box probe was competed with a sixfold
excess of unlabelled probes for unrelated GAL4 (lane 2), wild-
type M-box (lane 3), mutated M-box (lane 4) or wild-type
OTX2 site 3 (lane 5). Bottom panel, labeled E-box probe was
competed  with  a  sixfold  excess  of  unlabeled  probes  for
unrelated GAL4 (lane 2), wild-type E-box (lane 3), mutated
E-box (lane 4) or wild-type OTX2 site 3 (lane 5). Specific
DNA–protein complexes are indicated with symbols A, A1 or
A2  while  non-specific  complexes  are  indicated  with  B.
Binding reactions in the absence of competitor are on lanes 1.
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